AU2002307154A1 - Prostate cancer expression profiles - Google Patents

Prostate cancer expression profiles

Info

Publication number
AU2002307154A1
AU2002307154A1 AU2002307154A AU2002307154A AU2002307154A1 AU 2002307154 A1 AU2002307154 A1 AU 2002307154A1 AU 2002307154 A AU2002307154 A AU 2002307154A AU 2002307154 A AU2002307154 A AU 2002307154A AU 2002307154 A1 AU2002307154 A1 AU 2002307154A1
Authority
AU
Australia
Prior art keywords
prostate cancer
expression profiles
cancer expression
profiles
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002307154A
Inventor
Gilbert Jay
Zairen Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Origene Technologies Inc
Original Assignee
Origene Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Origene Technologies Inc filed Critical Origene Technologies Inc
Publication of AU2002307154A1 publication Critical patent/AU2002307154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2002307154A 2001-04-06 2002-04-08 Prostate cancer expression profiles Abandoned AU2002307154A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28173201P 2001-04-06 2001-04-06
US28173101P 2001-04-06 2001-04-06
US60/281,732 2001-04-06
US60/281,731 2001-04-06
PCT/US2002/010824 WO2002081638A2 (en) 2001-04-06 2002-04-08 Prostate cancer expression profiles

Publications (1)

Publication Number Publication Date
AU2002307154A1 true AU2002307154A1 (en) 2002-10-21

Family

ID=26961049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002307154A Abandoned AU2002307154A1 (en) 2001-04-06 2002-04-08 Prostate cancer expression profiles

Country Status (2)

Country Link
AU (1) AU2002307154A1 (en)
WO (1) WO2002081638A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092009A1 (en) 2000-11-16 2003-05-15 Kaia Palm Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
CA2484251C (en) 2002-04-30 2015-06-23 University Of South Florida Materials and methods for inhibition of respiratory syncytial virus infection
EP1552845A4 (en) * 2002-06-26 2006-06-07 Takeda Pharmaceutical Preventives/remedies for cancer
US7595303B1 (en) 2002-09-05 2009-09-29 University Of South Florida Genetic adjuvants for immunotherapy
AU2003274970A1 (en) * 2002-09-10 2004-04-30 Guennadi V. Glinskii Gene segregation and biological sample classification methods
DE10341812A1 (en) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
EP1856287B1 (en) * 2005-02-14 2011-09-28 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of age-related macular degeneration
EP1872134A4 (en) * 2005-04-12 2010-09-01 Cell Signaling Technology Inc Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
EP1957672A2 (en) * 2005-10-28 2008-08-20 Biomerieux Sa Method for detecting cancer
AU2008259792B2 (en) * 2007-06-03 2013-08-22 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
US7998688B2 (en) 2008-03-07 2011-08-16 OSI Pharmaceuticals, LLC Inhibition of EMT induction in tumor cells by anti-cancer agents
EP3214444A1 (en) * 2016-03-04 2017-09-06 AIT Austrian Institute of Technology GmbH Prostate cancer diagnostic method and means

Also Published As

Publication number Publication date
WO2002081638A2 (en) 2002-10-17
WO2002081638A3 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
AU2003201741A1 (en) Cancer profiles
AU2002360769A1 (en) Breast cancer expression profiling
AUPS054702A0 (en) Cancer therapy
AU2003294205A1 (en) Prostate cancer biomarkers
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AUPR395801A0 (en) Antibodies against cancer
AU2002226650A1 (en) Redox therapy for tumors
EP1223289A3 (en) Doors
AU2002367073A1 (en) Constant coverage waveguide
AU2002360345A1 (en) Prostate cancer genes
AU2002307154A1 (en) Prostate cancer expression profiles
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
AU2003279101A1 (en) Methylation profile of cancer
AU2002308642A1 (en) Methods for treating cancer
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
EP1298277A3 (en) Doors
AU2002335667A1 (en) Modified reoviral therapy
AU2003212826A1 (en) Cancer genes
AU2003283339A1 (en) Cancer therapy determination
AU2001257325A1 (en) Cancer treatment
AU2002351382A1 (en) Combination cancer therapy
AU2001257168A1 (en) Cancer treatment
GB0123630D0 (en) cancer
GB0115673D0 (en) Cancer
GB0127668D0 (en) Cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase